Epizyme (EPZM) To Present At Upcoming Conferences In September
8/26/2014 10:24:16 AM
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in five upcoming conferences in September:
Help employers find you! Check out all the jobs and post your resume.
comments powered by